Search

Your search keyword '"Preuss, Klaus-Dieter"' showing total 340 results

Search Constraints

Start Over You searched for: Author "Preuss, Klaus-Dieter" Remove constraint Author: "Preuss, Klaus-Dieter"
340 results on '"Preuss, Klaus-Dieter"'

Search Results

1. Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis

2. Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

3. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study

4. LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

6. Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

7. Characterization of rare germline variants in familial multiple myeloma

8. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma

9. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting

10. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

11. B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma

13. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells

14. IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

16. Progranulin antibodies in autoimmune diseases

17. B‐cell receptors of EBV‐negative Burkitt lymphoma bind modified isoforms of autoantigens

18. Autoantibodies against SUMO1-DHX35 in long-COVID

22. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor

24. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study

28. Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19

29. Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children

34. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells

38. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma

46. Role of specific B-cell receptor antigens in lymphomagenesis

50. The B-Cell Receptor Antigen ARS2 Can be Integrated into a BAR-Body Format to Treat Diffuse Large B-Cell Lymphomas in Xenograft Mouse Models

Catalog

Books, media, physical & digital resources